Understanding Cutaneous Vasculitis: Causes, Symptoms, Treatment

Medically Reviewed by Dr. Sony Sherpa, (MBBS) - October 30, 2026

Fact Checked and Edited by Dr. Rae Osborn, Ph.D. - October 30, 2026

What Is Cutaneous Vasculitis?

Cutaneous vasculitis is a group of inflammatory disorders that affect the blood vessels in the skin. The inflammation damages vessel walls, leading to visible skin changes, such as rashes, spots, ulcers, or nodules. It may occur on its own or as part of a broader systemic condition.

Early recognition is important because cutaneous vasculitis can sometimes signal an underlying infection, autoimmune disease, medication reaction, or systemic vasculitis affecting internal organs. Prompt diagnosis enables appropriate treatment, helps prevent complications, and improves long-term outcomes, especially if other organs become involved.

Cutaneous vasculitis is considered relatively uncommon, though exact prevalence varies by population and diagnostic criteria. It can affect individuals of all ages, but certain types are more common in adults, particularly those with autoimmune conditions, chronic infections, or exposure to specific medications.

Understanding Cutaneous Vasculitis

Primary Cutaneous Vasculitis

Primary cutaneous vasculitis occurs as an isolated skin condition without an identifiable underlying systemic disease. Inflammation originates in the skin's blood vessels, and many cases are idiopathic, meaning no clear cause can be identified. Examples include idiopathic cutaneous small-vessel vasculitis and primary cutaneous polyarteritis nodosa (cPAN), which is limited to the skin.

Secondary Cutaneous Vasculitis

Secondary cutaneous vasculitis occurs as a manifestation of another disease or trigger. Common causes include viral or bacterial infections, medications, autoimmune or connective tissue disorders, and malignancies. Skin vasculitis may also occur as part of systemic vasculitides, such as ANCA-associated vasculitis, or in conditions such as rheumatoid arthritis and lupus (systemic lupus erythematosus).

Classification of Cutaneous Vasculitis

Cutaneous vasculitis can be classified by inflammatory cell type, vessel size, clinical patterns, and pathology.

Small Vessel Vasculitis

Involves arterioles, capillaries, and postcapillary venules in the dermis.

Key types include:

• Cutaneous small-vessel vasculitis (CSVV) – Also called cutaneous leukocytoclastic vasculitis​; often idiopathic
• Idiopathic cutaneous small-vessel vasculitis – No identifiable trigger
• Leukocytoclastic vasculitis (LCV) (also known as leukocytoclastic angiitis)– Characterized microscopically by neutrophils and fragments of their nuclei
• Hypersensitivity vasculitis – A term previously used when a drug or infection was identified as the cause
• Bullous leukocytoclastic vasculitis (LCV) is an uncommon blistering presentation. Besides the characteristic purpuric rash, affected skin may develop fluid-filled blisters (bullae) or blood-filled vesicles. Extensive blistering or ulceration can occur

Also included in small vessel categories:

• IgA vasculitis (formerly known as Henoch-Schönlein purpura)
• Urticarial vasculitis
• Cryoglobulinemic vasculitis
• Erythema elevatum diutinum
• ANCA-associated small vessel forms (including granulomatosis with polyangiitis (GPA), microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis (EGPA)

Medium Vessel Vasculitis

• Affects deeper, muscular arteries in the skin and subcutis

An example is cutaneous polyarteritis nodosa, which mainly affects medium vessels in the skin, producing nodules, ulcers, and livedo reticularis/racemosa – a net-like, reddish-purple pattern on the skin

Large Vessel Vasculitis

• Usually systemic (e.g., Giant Cell Arteritis, Takayasu)
• May have skin manifestations like livedo reticularis or ulceration when deep vessels are involved

What Are the Common Histopathological Features?

Histology is essential for confirming vasculitis and identifying vessel size and inflammatory type.

Patterns Seen on Biopsy

Acute vasculitis (often small vessel)

• Fibrinoid necrosis - severe damage to blood vessel walls (eosinophilic, protein-rich material replacing normal architecture)
• Neutrophilic infiltrate - buildup of neutrophils in and around vessels
• Leukocytoclasia — nuclear debris (“nuclear dust”) from the breakdown of neutrophil nuclei
• Extravasated red blood cells - Red blood cells leaking into the surrounding skin, causing purple spots (purpura)
• Endothelial swelling and perivascular edema - Swelling of the cells lining blood vessels and fluid buildup around them

Chronic or lymphocytic patterns

• Lymphocytes and plasma cells may predominate in longer-standing lesions

Medium vessel changes

• In cPAN, medium arteries show inflammation and damage to certain sections of their walls, sometimes accompanied by blood clot formation

Signs and Symptoms

Early Warning Signs

• Palpable purpura (raised, non-blanching purple or red spots), most commonly on the lower legs
• Vasculitis petechiae or small red-purple dots
• Urticarial-like lesions that last longer than typical hives
• Blisters, nodules, or shallow ulcers in more severe cases
• Burning, stinging, tenderness, or pain at lesion sites
• Itching may occur but is less prominent than pain or tenderness

Systemic Symptoms

While cutaneous vasculitis symptoms may typically be limited to the skin, systemic symptoms can occur, especially in secondary forms:

• Fever and fatigue
• Malaise and weight loss
• Arthralgia or arthritis
• Abdominal pain (particularly in IgA-associated disease)
• Hematuria or renal involvement (suggesting systemic vasculitis)

Livedo Reticularis (LR)

Livedo reticularis refers to a net-like, violaceous discoloration of the skin resulting from impaired blood flow in dermal vessels. As discussed above, it is more commonly associated with medium-vessel vasculitis, including cutaneous polyarteritis nodosa, which may also present with livedo racemosa, or with systemic disease.

Acute vs. Chronic Presentation

Acute cutaneous vasculitis

• Sudden onset of lesions
• Often linked to infections or medications
• Typically self-limited and resolves within weeks

Chronic or recurrent cutaneous vasculitis

• Persistent or relapsing lesions over months to years
• May be idiopathic or associated with autoimmune or systemic disease
• Greater risk of ulceration, scarring, and pigmentation changes

Pediatric vs. Adult Presentation

Pediatric

More commonly associated with IgA vasculitis

• Often preceded by upper respiratory infections
• Has systemic involvement (gastrointestinal or renal) more frequently
• Generally a better prognosis

Adult

• More often idiopathic or medication-related
• Higher likelihood of underlying systemic disease and malignancy
• Chronic or relapsing forms are more common

What Causes Cutaneous Vasculitis? Etiology & Risk Factors

Idiopathic

• A significant proportion of cases have no identifiable cause, especially in cutaneous small-vessel vasculitis

Infections

• Bacterial (e.g., streptococcal infections)
• Viral (e.g., hepatitis B or C, HIV)
• Infection-related immune complex deposition can sometimes trigger vessel inflammation

Medications

• Common triggers include:
  • Antibiotics (e.g., beta-lactams, sulfonamides)
  • Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Vasculitis usually develops days to weeks after exposure

Systemic Diseases

• Autoimmune and connective tissue disorders (e.g., lupus, rheumatoid arthritis)
• ANCA-associated vasculitides
• Inflammatory bowel disease
• Hematologic or solid malignancies (less common, in 5% of cases)

Other Triggers

• Vaccinations, but more evidence is needed
• Cold exposure
• Rarely, food additives or allergens
• Physical trauma to the skin or prolonged standing

Is Vasculitis Hereditary?

Cutaneous vasculitis itself is not considered hereditary for small vessel vasculitis. However, genetic susceptibility may influence immune responses in some cases, potentially increasing the risk of developing autoimmune or inflammatory diseases associated with vasculitis. Genetic susceptibility can occur for some types of vasculitis, e.g., IgA vasculitis. The contribution of genetics varies by type of vasculitis, and evidence for inherited susceptibility to cutaneous vasculitis confined to the skin remains limited.

Diagnosis

Clinical Examination

• Careful assessment of the pattern, distribution, and evolution of skin lesions
• Typical findings include palpable purpura, often symmetrically distributed on the lower extremities
• Evaluation for features suggesting deeper vessel involvement (nodules, ulcers, livedo reticularis)
• Assessment for systemic symptoms, such as fever, joint pain, abdominal pain, or renal symptoms (as indicated by hematuria), to rule out systemic vasculitis

Laboratory Tests

Used to assess inflammation, identify triggers, and detect systemic involvement. These could be listed as follows:

• Complete blood count (CBC) – Anemia, leukocytosis, thrombocytopenia
• Inflammatory markers – ESR and CRP (often elevated)
• Autoimmune markers – ANA, ANCA, complement levels, rheumatoid factor (when indicated)
• Infection screening – Hepatitis B and C, HIV, streptococcal testing when clinically relevant
• Urinalysis – To detect renal involvement (proteinuria or hematuria)

Skin Biopsy

• Histopathology of a skin biopsy is the gold standard for diagnosis
• Should be performed on a new lesion (ideally within 24–48 hours old)
• Confirms vasculitis, identifies vessel size involved, and helps distinguish leukocytoclastic vasculitis from other mimickers
• Direct immunofluorescence may demonstrate immune complex deposition (e.g., IgA) in vessel walls

Imaging

• Not routinely required for skin-limited disease
• Imaging is chosen based on the suspected organ involvement and type of vasculitis
• When systemic involvement is suspected, investigations may involve:
  • Chest imaging for pulmonary symptoms
  • Abdominal imaging for gastrointestinal involvement
  • Vascular imaging if medium or large vessel disease is suspected

What Can Mimic Cutaneous Vasculitis? Differential Diagnosis

Cutaneous Vasculitis vs. Cellulitis

Cutaneous small vessel vasculitis typically presents with bilateral, non-blanching purpura that is often palpable. In contrast, cellulitis usually affects one side of the body and is characterized by warm, tender, erythematous skin, often accompanied by systemic signs of infection. Unlike cellulitis, cutaneous vasculitis generally lacks the diffuse, poorly demarcated (faded edges) erythema characteristic of the infection.

Cutaneous Vasculitis vs. Lupus Rash

Lupus rashes can resemble the skin lesions associated with cutaneous vasculitis, making it difficult to distinguish between the two conditions. Lupus and cutaneous vasculitis may also occur together. Autoimmune testing and skin biopsy can help differentiate between them.

Cutaneous Vasculitis vs. Urticaria

Urticaria typically presents with itchy, blanching wheals that resolve within 24 hours without leaving marks. In contrast, cutaneous vasculitis may cause persistent, non-blanching purpura or urticarial-like lesions that last longer than 24 hours and leave bruising or residual pigmentation. Lesions associated with pain or burning, prolonged duration, or residual skin changes may suggest urticarial vasculitis, and a skin biopsy can help distinguish it from ordinary urticaria.

Cutaneous Vasculitis vs. Thrombotic Vasculopathies

Cutaneous vasculitis involves inflammation and damage to blood vessel walls, often resulting in palpable purpura. In contrast, thrombotic vasculopathies involve blood vessel blockage by clots and may present with retiform purpura, net-like skin discoloration, painful lesions, or ulcers. A skin biopsy can help distinguish inflammatory vessel-wall damage from intravascular thrombosis, while clinical findings and relevant investigations can help identify the underlying cause.

Cutaneous Vasculitis vs. Capillaritis

Cutaneous vasculitis involves inflammation and damage to blood vessel walls and often presents with palpable purpura. In contrast, capillaritis typically involves leakage of red blood cells from superficial capillaries, resulting in flat, non-palpable purpura and reddish-brown pigmentation. Unlike cutaneous vasculitis, pigmented purpuric dermatoses generally do not show destructive inflammation of the vessel wall. Clinical findings and, when indicated, skin biopsy can help distinguish the two conditions.
Examples of pigmented purpuric dermatoses (PPD) include progressive pigmented purpura (Schamberg disease), which is a capillaritis rash, lichen aureus, and pigmented purpuric lichenoid dermatosis; this PPD group is primarily cosmetic and usually benign.

Cutaneous Vasculitis Treatment Options

Treatment depends on whether you have a mild cutaneous vasculitis or more severe illness.

Mild, Skin-Limited Disease

• Rest and reassurance
• Avoidance of identified triggers (e.g., offending medications, infections)
• Topical corticosteroids for symptomatic relief
• Supportive measures:
  • Avoid prolonged standing
  • Elevation of the legs
  • Use of compression stockings

Moderate to Severe Disease or Systemic Involvement

• Systemic corticosteroids for rapid control of inflammation
• Immunosuppressive agents in persistent or severe cases:
  • Azathioprine
  • Methotrexate
  • Mycophenolate mofetil
  • Cyclophosphamide (for severe, organ-threatening disease)
• Targeted biologic therapies may be considered for refractory cases

Why Is It Important to Treat the Underlying Cause?

Identifying and managing underlying infections, autoimmune diseases, or medication-related triggers is essential in treating cutaneous vasculitis. Effective treatment of the underlying condition may lead to the resolution of cutaneous vasculitis and help reduce the risk of recurrence.

Complications

The complications of cutaneous vasculitis can include:

• Chronic skin ulcers, particularly in medium-vessel disease or recurrent inflammation of blood vessels
• Scarring following ulceration or deep tissue damage
• Post-inflammatory pigment changes, including hyperpigmentation or hypopigmentation
• Medication-related side effects, such as infection risk, osteoporosis, hypertension, or liver toxicity from long-term corticosteroids or immunosuppressants
• Systemic involvement, which significantly worsens prognosis and may affect the kidneys, gastrointestinal tract, joints, or other organs

Prognosis for Cutaneous Vasculitis

Cutaneous vasculitis limited to the skin is usually self-limiting and has a favorable prognosis. However, the overall prognosis depends on several factors, including the size of the blood vessels involved, the presence or absence of systemic disease, the response to treatment, and how effectively the underlying causes are controlled.

How Long Does It Last?

Acute cases of cutaneous vasculitis often resolve within a few weeks to a few months. However, chronic or recurrent cases may persist or relapse over months to years, particularly when associated with systemic disease.

Can It Be Cured?

Skin-limited cutaneous vasculitis can often resolve completely, particularly when the underlying trigger is identified and removed. However, chronic or secondary forms may not be permanently curable, although they can usually be managed with appropriate treatment and monitoring.

When to Seek Immediate Medical Attention

Immediate medical attention is necessary if purpura spreads rapidly or skin lesions suddenly worsen, or if painful, non-healing ulcers or signs of skin infection develop. Symptoms suggesting systemic involvement also require urgent evaluation, including persistent fever, blood in the urine or reduced urine output (which may indicate kidney involvement), severe abdominal pain, gastrointestinal bleeding, shortness of breath, or other chest symptoms.

Living With Cutaneous Vasculitis: Lifestyle, Monitoring, and Follow-up

Skin Care to Prevent Secondary Infection

• Keep affected skin clean and dry
• Use gentle, non-irritating cleansers and emollients
• Avoid scratching or trauma to lesions
• Promptly treat open sores or ulcers to prevent bacterial infection
• Seek medical care if signs of infection appear (increasing redness, warmth, pus)

Regular Follow-Up

• Periodic follow-up is important to:
  • Monitor resolution or recurrence of skin lesions
  • Detect early systemic involvement (renal, gastrointestinal, or joint symptoms)
  • Adjust medications and minimize long-term treatment side effects; however, sometimes, more potent medicines are needed
• Patients with recurrent or chronic disease may require long-term monitoring

Trigger Avoidance

• Discontinue suspected offending medications when possible
• Prompt treatment of infections
• Avoid prolonged standing; elevate legs when resting
• Use compression stockings if lower-leg involvement is prominent
• Avoid known personal triggers once identified

Frequently Asked Questions

Can amlodipine cause cutaneous vasculitis?

Yes. Although uncommon, amlodipine and other calcium channel blockers have been reported to trigger cutaneous small-vessel vasculitis, possibly through a hypersensitivity reaction.

Can methotrexate be used for vasculitis?

Yes. Methotrexate is used as a steroid-sparing immunosuppressant in chronic, recurrent, or systemic vasculitis, including some cases of cutaneous vasculitis.

Can cutaneous vasculitis cause pneumonia?

Cutaneous vasculitis itself does not cause pneumonia, but symptoms may resemble pneumonia. However, vasculitis associated with systemic disease may involve the lungs, leading to pulmonary inflammation or bleeding that can resemble pneumonia.

Can Sjögren’s syndrome cause vasculitis?

Yes. Sjögren’s syndrome is a known cause of secondary cutaneous vasculitis, particularly small-vessel and immune complex–mediated vasculitis.

Can vaccinations help reduce cutaneous vasculitis?

Vaccinations do not directly treat vasculitis. Rarely, vaccines may trigger vasculitis. If you already have vasculitis or are taking immunosuppressants, you should check with your doctor first before vaccination because certain vaccines shouldn’t be given in some situations.

To search for the best Dermatology Healthcare Providers and Doctors in India, Malaysia, Spain, the UAE, the UK, and the USA, please use the Mya Care search engine.

To search for the best doctors and healthcare providers worldwide, please use the Mya Care search engine.

 

References:

Show All ▼

 

Disclaimer